Skip to Content on Nemours.org

News Coverage

Recent news headlines featuring Nemours Children's Health.

Advanced Search
  • Jan 8, 2026
    Becker's Healthcare Podcast

    In this episode, Caswell Samms III, Executive Vice President and CFO of Nemours Children’s Health, discusses financial priorities for 2026, including purposeful growth, Medicaid reimbursement pressures, and strategic investments in maternal care and virtual health. He also shares how CFOs must lead with agility, clinical insight, and mission focus in an uncertain healthcare landscape.

  • Jan 7, 2026
    Becker's Hospital Review

    “While the pressures on healthcare institutions are real, I am proud to share that Nemours Children’s Health grew our workforce in 2025 and made meaningful, purposeful investments in our people and culture,” Mr. Baptiste told Becker’s. “In 2026, we are accelerating our efforts to retain, develop, and recruit the right talent to advance our Whole Child Health strategy.”

    The system continues to prioritize building a healthy workforce to support excellent patient care.

  • Jan 7, 2026
    Becker's Hospital Review

    KidsHealth, which recently marked its third decade of existence and surpassed 6 billion page views, features free, physician-approved articles, illustrations, newsletters, patient care instructions and videos. It is also the most-cited pediatric website by AI chatbots such as ChatGPT and Google Gemini.

  • Dec 3, 2025
    Parents

    Our kids are growing up in a very different world than we did. Given the advancements in technology that are now part of our kids’ lives, Lian Liu, PhD, a pediatric psychologist with Nemours Children's Health, points out that embarrassment—a normal part of growing up, to be fair—can be more acute and intense than in the past.

  • Dec 2, 2025
    Healio

    Linhda Nguyen, PA-C, a physician assistant at the Healthy Weight and Wellness Clinic at Nemours Children’s Health in Wilmington, Delaware, said GLP-1 prescriptions for adolescents have increased since the approval of semaglutide (Wegovy, Novo Nordisk) in 2022.

Show 5102550100 per page